Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_17a65bc83ed569f525294332fa4787fc |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505 |
filingDate |
2015-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2018-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8878b17d132047b83bfc25efe6fcb143 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06d302ad568d084d6d7621ee30686724 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef9e3b91188c8fc9a8b8c54c4ca43f7f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_929643d9216f3570c7ae2f948fab3bbb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94efa2c23603aba85dfa892f02a5fdd1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d858b21ee0550ac8854ad5a62780b2d8 |
publicationDate |
2018-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
AU-2015275321-B2 |
titleOfInvention |
The use of inhibitors of Bruton's tyrosine kinase (Btk) |
abstract |
THE USE OF INHIBITORS OF BRUTON'S TYROSINE KINASE (BTK) Abstract: Disclosed herein are methods for treating a cancer comprising: a. administering a Btk inhibitor to a subject sufficient to result in an increase or appearance in the blood of a subpopulation of lymphocytes defined by immunophenotyping; b. determining the expression profile of one or more biomarkers from one or more subpopulation of lymphocytes; and c. administering a second agent based on the determined expression profile. (1 Rd7fl1 11-MCH |
priorityDate |
2010-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |